Christopher Robinson/LinkedIn
May 20, 2026, 07:27
Christopher Robinson: SNRI vs SSRI and the Risk of Hypertensive Disorders of Pregnancy
Christopher Robinson, Associate Professor Maternal Fetal Medicine at University of South Carolina, shared a post on LinkedIn:
“AJOG Presents: Serotonin-norepinephrine reuptake inhibitors vs selective serotonin reuptake inhibitors and the risk of hypertensive disorders of pregnancy.”
Title: Serotonin-norepinephrine reuptake inhibitors vs selective serotonin reuptake inhibitors and the risk of hypertensive disorders of pregnancy
Authors: Anick Bérard, Yves Mufike Lumu, Odile Sheehy, Gabra Nohmie, Narimene Ait Belkacem
Proceed to the video attached to the post.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 29, 2026, 16:22Aysha O’Connor: One of the Hardest Parts of My Own Fertility Journey Was Loneliness…
-
Oct 29, 2026, 16:15Chaithra S K: Preimplantation Genetic Testing Still Requires an Embryo Biopsy
-
Oct 29, 2026, 16:11Filipina Woman’s Journey of Strength, Hope, and Finding Balance While Living with PCOS – PCOS Millennials
-
Oct 29, 2026, 15:58Eric Lameignere: Can DNA Fragmentation in Cumulus Cells Predict ICSI Outcomes?
-
Oct 29, 2026, 15:50Saadat Hassan: Sperm Function Testing – Can Advanced Diagnostics Guide IVF and ICSI Selection?
-
Oct 29, 2026, 15:34Sara Spiro: Celebrating the Stories Members Have Trusted With at Maven Clinic – Here Is Mine
-
Oct 29, 2026, 15:31Dina Ibrahem: 0 Motility, 1 Critical Decision
-
Oct 29, 2026, 15:28AI and Automation in Fertility and Genomics: Pipeline or Pipe Dream? – ARCS
-
Oct 29, 2026, 15:26Michael Schindler: Large Networks or Small Centers – Who Delivers Better Care?